Business Context and Reporting Period
Company: Progyny, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: January 9, 2023
Context: The filing serves to reaffirm the Company's previously issued financial guidance for the quarter and full year ending December 31, 2022.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document references a press release (Exhibit 99.1) containing the guidance details but does not embed the specific financial figures within the body of this 8-K report.
Material Changes
No material changes to financial performance or guidance were reported in this filing. The Company explicitly stated it is reaffirming its prior guidance for the three months and year ending December 31, 2022.
Guidance, Outlook, and Management Commentary
- Guidance Reaffirmation: Management confirmed that the financial outlook for the fourth quarter and full year 2022 remains unchanged from previous communications.
- Source of Details: Specific commentary and numerical targets are contained in the press release dated January 9, 2023, attached as Exhibit 99.1.
- Legal Disclaimer: The information furnished under Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other SEC filings.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated January 9, 2023) for the specific numerical guidance figures for Q4 and FY 2022.
- Verify the Company's actual performance against the reaffirmed guidance once the Q4 2022 earnings are officially released.
- Monitor subsequent filings for any updates to the guidance reaffirmed in this report.